1. Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy
   Juan Bautista De Sanctis et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
2. IL-33/ST2 pathway in a bleomycin-induced pulmonary fibrosis model
   Jiao Xu et al, 2016, Molecular Medicine Reports CrossRef
3. Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
   Mariya Farooq et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
4. Glioblastoma as a Novel Drug Repositioning Target: Updated State
   Hamed Hosseinalizadeh et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
5. Expanding the Role of Chloroquine as a Potent Antineoplastic Agent in Different Gastrointestinal Malignancies
   Shailendra Kapoor, 2017, Chemotherapy CrossRef
6. Lysosomes as Oxidative Targets for Cancer Therapy
   Rebecca F. Dielschneider et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
7. Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone
   Bashir Lawal et al, 2022, Computers in Biology and Medicine CrossRef
8. Reactive fibrosis precedes doxorubicin‐induced heart failure through sterile inflammation
   Ryo Tanaka et al, 2020, ESC Heart Failure CrossRef
9. Toll-Like Receptor 9-Mediated Neuronal Innate Immune Reaction Is Associated with Initiating a Pro-Regenerative State in Neurons of the Dorsal Root Ganglia Non-Associated with Sciatic Nerve Lesion
   Petr Dubový et al, 2021, International Journal of Molecular Sciences CrossRef
10. Chloroquine prevents hypoxic accumulation of HIF-1α by inhibiting ATR kinase: implication in chloroquine-mediated chemosensitization of colon carcinoma cells under hypoxia
    Changyu Kang et al, 2023, Pharmacological Reports CrossRef
11. Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
    L. E. Anselmino et al, 2023, Scientific Reports CrossRef
12. Chloroquine inhibits pro-inflammatory effects of heme on macrophages and in vivo
    Rafael Cardoso Maciel Costa Silva et al, 2021, Free Radical Biology and Medicine CrossRef
13. TLR9 Exerts an Oncogenic Role in Promoting Osteosarcoma Progression Depending on the Regulation of NF-κB Signaling Pathway
    Yongbin Jing et al, 2022, Biological and Pharmaceutical Bulletin CrossRef
14. Hydroxychloroquine in rheumatic autoimmune disorders and beyond
    Eliise Laura Nirk et al, 2020, EMBO Molecular Medicine CrossRef
15. 25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via the TLR2/NF-κB signaling pathway
    Saisai Wang et al, 2019, International Journal of Oncology CrossRef
16. Application of chloroquine as an endosomal escape enhancing agent: new frontiers for an old drug
    Mohammad Hajimolaali et al, 2021, Expert Opinion on Drug Delivery CrossRef
17. Tanshinone IIA decreases the migratory ability of AGS cells by decreasing the protein expression of matrix metalloproteinases, nuclear factor κB-p65 and cyclooxygenase-2
    CHIN-CHENG SU, 2016, Molecular Medicine Reports CrossRef
18. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts
    Shivika S. Gupta et al, 2016, Oncotarget CrossRef
19. Differential role of vacuolar (H+)-ATPase in the expression and activity of cyclooxygenase-2 in human monocytes
    Zhigang Rao et al, 2020, Biochemical Pharmacology CrossRef